Stock 301507 HANGZHOU MINSHENG HEALTHCARE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hangzhou Minsheng Healthcare Co., Ltd.

Equities

301507

CNE1000068Q3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
12.88 CNY +2.14% Intraday chart for Hangzhou Minsheng Healthcare Co., Ltd. +1.18% -21.94%
05-20 Hangzhou Minsheng Healthcare Co., Ltd. Approves Cash Dividend for the Year 2023 CI
05-20 Hangzhou Minsheng Healthcare Co., Ltd. Approves Board Appointments CI

Valuation

Fiscal Period: December 2023
Capitalization 1 5,883
Enterprise Value (EV) 1 4,900
P/E ratio 56.9 x
Yield 0.61%
Capitalization / Revenue 10.1 x
EV / Revenue 8.42 x
EV / EBITDA 46.7 x
EV / FCF 119 x
FCF Yield 0.84%
Price to Book 3.99 x
Nbr of stocks (in thousands) 356,554
Reference price 2 16.50
Announcement Date 23/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 439.4 489.6 547.1 581.7
EBITDA 1 91.22 91.42 106 104.9
EBIT 1 62.8 61.89 75.4 79.02
Operating Margin 14.29% 12.64% 13.78% 13.58%
Earnings before Tax (EBT) 1 62.42 78.94 88.07 96.8
Net income 1 50.72 70.22 78.98 85.63
Net margin 11.54% 14.34% 14.44% 14.72%
EPS 2 0.2131 0.2700 0.3000 0.2900
Free Cash Flow 1 -8.338 91.88 47.36 41.17
FCF margin -1.9% 18.77% 8.66% 7.08%
FCF Conversion (EBITDA) - 100.51% 44.69% 39.24%
FCF Conversion (Net income) - 130.84% 59.96% 48.07%
Dividend per Share - - - 0.1000
Announcement Date 10/08/23 10/08/23 10/08/23 23/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 136 252 122 983
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -8.34 91.9 47.4 41.2
ROE (net income / shareholders' equity) 13% 14.6% 14.2% 8.29%
ROA (Net income/ Total Assets) 6.45% 5.68% 6.52% 4.09%
Assets 1 785.7 1,236 1,212 2,092
Book Value Per Share 2 1.880 1.980 2.220 4.130
Cash Flow per Share 2 0.2300 0.0900 0.1800 1.200
Capex 1 7.31 25.6 26.9 36.1
Capex / Sales 1.66% 5.22% 4.92% 6.2%
Announcement Date 10/08/23 10/08/23 10/08/23 23/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
HANGZHOU MINSHENG HEALTHCARE CO., LTD. Stock Hangzhou Minsheng Healthcare Co., Ltd.
-21.94% 634M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301507 Stock
  4. Financials Hangzhou Minsheng Healthcare Co., Ltd.